Episode 338. Air Date: 06/29/14
Praveen R Arany D.D.S., Ph.D.
Dr. Arany competed his initial dental training in general dentistry and residency in Oral Pathology in 2001 from India. He did postdoctoral fellowships in basic sciences at the Indian Institute of Sciences, Bangalore, India and National Cancer Institute, NIH, Bethesda. He then completed a PhD-Residency program at Harvard University in 2011 and was a Harvard Presidential Scholar. He is currently an Assistant Clinical Investigator at the National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda. He has over 40 publications including 3 book chapters and is the recipient of numerous awards such as the NCI Director's Young Investigator Award, NIH Merit award, Wound Healing Society's Young Investigator Award, Eugene Seidner scholar, among others. He has been invited to speak in various national and international forums. He is currently associate editor of the International Journal of Oral & Maxillofacial Biology and member of various committees of Wound Healing Society and American Association of Dental Research. He reviews for many journals including Journal of Dental Research, Lasers in Medical Sciences, Photomedicine and Laser Surgery, Wound Repair and Regeneration, Cleft Plate and Craniofacial Journal Biology, Triple O, Tissue Engineering, among others. Dr. Arany is currently President-elect of North American Association for Light Therapy, Chair of Lasers in Dentistry, Special interest group of the American Dental Education Association.
Dr. Arany’s research is focused on the molecular mechanisms and clinical applications of light therapy to promote wound healing and tissue regeneration. Dr. Arany's scientific interests have focused on the role of growth factor signaling in wound healing and regeneration. His lab attempts to identify key biological regulatory components that can be used in clinical studies to control biological outcomes. His lab uses a range of cell and molecular biology tools in tissue culture and scaffold-based model systems. Further, a large emphasis is placed on validation in animal models and moving them forward into human clinical studies. His other major areas of interest are the molecular dichotomy of wounds and tumors, cell signaling regulatory networks and Transforming Growth Factor-β biology.
Add new comment